Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential

被引:4
|
作者
Ruan, Danhua [1 ,2 ]
Wen, Jirui [3 ]
Fang, Fei [4 ]
Lei, Yuqin [1 ]
Zhao, Zhiwei [4 ]
Miao, Yali [1 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Key Lab Birth Defects & Related Dis Women & Childr, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Deep Underground Space Med Ctr, Chengdu 610041, Sichuan, Peoples R China
[4] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Sichuan, Peoples R China
基金
中央高校基本科研业务费专项资金资助;
关键词
CELL-DEATH RECOMMENDATIONS; PROMOTES FERROPTOSIS; STEM-CELLS; MECHANISMS; RESISTANCE; PATHWAY; GROWTH;
D O I
10.1038/s41420-023-01721-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epithelial ovarian cancer (EOC) is universally acknowledged as a terrifying women killer for its high mortality. Recent research advances support that ferroptosis, an emerging iron-dependent type of regulated cell death (RCD) triggered by the excessive accumulation of lipid peroxides probably possesses extraordinary therapeutic potential in EOC therapy. Herein, we firstly provide a very concise introduction of ferroptosis. Special emphasis will be put on the ferroptosis's vital role in EOC, primarily covering its role in tumorigenesis and progression of EOC, the capability of reversing chemotherapy resistance, and the research and development of related therapeutic strategies. Furthermore, the construction of ferroptosis-related prognostic prediction systems, and mechanisms of ferroptosis resistance in EOC are also discussed. Finally, we propose and highlight several important yet unanswered problems and some future research directions in this field.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
    Li, Xiaoduan
    Wang, Xipeng
    MOLECULAR CANCER, 2017, 16
  • [22] The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
    Sheng, Q.
    Liu, J.
    BRITISH JOURNAL OF CANCER, 2011, 104 (08) : 1241 - 1245
  • [23] The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
    Q Sheng
    J Liu
    British Journal of Cancer, 2011, 104 : 1241 - 1245
  • [24] CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy
    Bai, Xupeng
    Feng, Xiaojie
    Ni, Jie
    Beretov, Julia
    Deng, Junli
    Zhu, Ying
    Graham, Peter
    Li, Yong
    CANCER RESEARCH, 2019, 79 (13)
  • [25] The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
    Gui, Ting
    Shen, Keng
    CANCER EPIDEMIOLOGY, 2012, 36 (05) : 490 - 496
  • [26] BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
    Clark-Knowles, Katherine V.
    O'Brien, Anna M.
    Weberpals, Johanne I.
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [27] mTORC2 is a promising therapeutic target in epithelial ovarian cancer
    Hisamatsu, Takeshi
    Mabuchi, Seiji
    Hashimoto, Kae
    Isobe, Aki
    Sawada, Kenjiro
    Kimura, Tadashi
    CANCER RESEARCH, 2012, 72
  • [28] PTK7 as a potential therapeutic target in ovarian cancer
    Ding, Zhihu
    Lennon, Amanda
    Perron, Keli
    Harper, David
    Su, Hui
    Wolfram, Meredith
    Murtie, Joshua
    Licht, Stuart
    Pinckney, Jason
    Simonds-Mannes, Helene
    Bishop, Kimberly
    Gavigan, Julie-Ann
    Bangari, Dinesh
    Magnay, Maureen
    Weber, William
    Reczek, David
    Brondyk, William
    Drewett, Vicky
    Trombe, Marc
    Hoffmann, Dietmar
    Baffa, Raffaele
    Silver, Serena
    Richon, Victoria
    Winter, Christopher
    Reddy, Venkat
    Gregory, Richard C.
    CANCER RESEARCH, 2014, 74 (19)
  • [29] HDAC10 as a potential therapeutic target in ovarian cancer
    Islam, Muhtadi M.
    Banerjee, Tapahsama
    Packard, Colin Z.
    Kotian, Shweta
    Selvendiran, Karuppaiyah
    Cohn, David E.
    Parvin, Jeffrey D.
    GYNECOLOGIC ONCOLOGY, 2017, 144 (03) : 613 - 620
  • [30] KRCC1: A potential therapeutic target in ovarian cancer
    Dwivedi, Shailendra Kumar Dhar
    Shameer, Khader
    Dey, Anindya
    Mustafi, Soumyajit Banerjee
    Xiong, Xunhao
    Bhattacharya, Udayan
    Neizer-Ashun, Fiifi
    Rao, Geeta
    Wang, Yue
    Ivan, Cristina
    Yang, Da
    Dudley, Joel T.
    Xu, Chao
    Wren, Jonathan D.
    Mukherjee, Priyabrata
    Bhattacharya, Resham
    FASEB JOURNAL, 2020, 34 (02): : 2287 - 2300